News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban Todd Neale March 23, 2018
News Daily News Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II Michael O'Riordan February 21, 2018
News Daily News USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women Caitlin E. Cox December 12, 2017
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Daily News Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months Michael O'Riordan December 01, 2016
News Daily News Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene L.A. McKeown July 13, 2015
News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015